市場調査レポート

商品コード

1741288

胸膜疾患市場：疾患タイプ別、診断ツール別、治療法別、エンドユーザー別、地域別

Pleural Diseases Market, By Disease Type, By Diagnostic Tools, By Treatment Modalities, By End User, By Geography

出版日: 2025年03月26日
発行: Coherent Market Insights
ページ情報: 英文 165 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,500 664,470円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,033,620円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,476,600円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=147.66円

全表示
概要
目次

概要

サンプル依頼リストに入れる

胸膜疾患市場は、2025年には57億6,000万米ドルと推定され、2032年には93億7,000万米ドルに達すると予測され、2025年から2032年までの年間平均成長率（CAGR）は7.2％で成長する見込みです。

レポート範囲		レポート詳細
基準年	2024	2025年の市場規模	57億6,000万米ドル
実績データ	2020年から2024年まで	予測期間	2025年から2032年
予測期間：2025年～2032年 CAGR：	7.20%	2032年の価値予測	93億7,000万米ドル

胸膜疾患は、肺を取り囲む薄い膜である胸膜に影響を及ぼす多様な疾患群を包含します。これらの疾患は、呼吸機能や全身の健康に大きな影響を与える可能性があります。胸膜は、潤滑を提供し、呼吸時のスムーズな動きを可能にすることで、肺の構造と機能の完全性を維持する上で重要な役割を果たしています。胸膜疾患は、感染症、炎症、腫瘍、有害物質への暴露など、さまざまな原因によって生じる可能性があります。一般的な胸膜疾患には、胸膜炎、胸水、気胸、中皮腫などがあります。症状を認識し、正確に診断し、適切な治療戦略を実施することは、これらの課題である世界の胸膜疾患に罹患した患者を管理し、予後を改善するために不可欠です。世界の胸膜疾患市場は、喫煙、結核、転移などの関連危険因子の有病率の上昇に牽引され、長年にわたり着実に成長しています。さらに、画像診断技術やレーザー治療などの診断・治療方法における著しい技術進歩が市場の成長をさらに後押ししています。

市場力学：

合意などの無機的戦略の採用が増加していることも、予測期間中の市場成長を促進すると予想されます。例えば、2020年11月、製薬会社である大鵬薬品工業株式会社と臨床段階のバイオ医薬品会社であるLung Therapeutics, Inc.は、Lung Tx社が現在開発中の遺伝子組み換えヒト一本鎖ウロキナーゼ型プラスミノゲンアクチベータの限局性胸水に対する日本領域での独占的ライセンス契約を発表しました。

しかし、認知度の低さや診断の遅れ、診断ツールや治療にかかる費用、専門知識やリソースの不足などが、予測期間中の世界の胸膜疾患市場の成長を妨げると予想されます。

本調査の主な特徴

本レポートは、世界の胸膜疾患市場を詳細に分析し、2024年を基準年とした予測期間2025-2032年の市場規模および複合年間成長率（CAGR）を提供します。
また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。
また市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などのパラメータに基づいて、世界の胸膜疾患市場の主要企業をプロファイルしています。
このレポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にします。
胸膜疾患の世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
利害関係者は、世界の胸膜疾患市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 5.76 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.20%	2032 Value Projection:	USD 9.37 Bn

Pleural diseases encompass a diverse group of conditions affecting the pleura, the thin membrane surrounding the lungs. These conditions can significantly impact respiratory function and overall well-being. The pleura plays a crucial role in maintaining the integrity of the lung's structure and function by providing lubrication and allowing smooth movement during breathing. Pleural diseases can arise from various causes, including infections, inflammation, tumors, and exposure to hazardous substances. Common pleural disorders include pleurisy, pleural effusion, pneumothorax and mesothelioma. Recognizing the symptoms, diagnosing accurately, and implementing appropriate treatment strategies are essential in managing and improving outcomes for individuals affected by these challenging global pleural diseases. The Global pleural diseases market has been steadily growing over the years driven by the rising prevalence of associated risk factors such as smoking, tuberculosis, and metastases. Furthermore, the market has witnessed significant technological advancements in diagnosis and treatment modalities such as imaging techniques and laser therapy, further supporting the market growth.

Market Dynamics:

The increasing adoption of inorganic strategies such as agreement is also expected to drive the growth of the market over the forecast period. For instance, in November 2020, Taiho Pharmaceutical Co., Ltd, a pharmaceutical company, and Lung Therapeutics, Inc., a clinical-stage biopharmaceutical company, announced an exclusive license agreement of LTI-01, a recombinant human single-chain urokinase plasminogen activator, currently under development by Lung Tx for loculated pleural effusions, for the territory of Japan.

However, limited awareness and delayed diagnosis, cost of diagnostic tools and treatment, limited availability of expertise and resources are expected to hamper growth of the global pleural diseases market over the forecast period.

Key features of the study:

This report provides an in-depth analysis of the global pleural diseases market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Global Pleural Diseases market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bristol Myers Squibb, Merck & Co., Inc., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Sanofi, AbbVie Inc., B. Braun SE, Becton, Dickinson and Company, Bicakcilar, Biometrix, Cook Medical, Grena, Redax, Rocket Medical, Smith Medical.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pleural diseases market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pleural diseases market

Global Pleural Diseases Market Segmentation Detailed Segmentation:

By Disease Types:
- Pleurisy
- Pleural Effusion
- Pneumothelioma
- Mesothelioma
- Others
By Diagnostic Tools:
- Imaging Techniques
- Molecular Diagnostics
- Thoracoscopy and Pleuroscopy
By Treatment Modalities:
- Medications
- Thoracentesis and Pleurodesis
- Minimally Invasive Interventions
- Surgical Interventions
By End User:
- Hospitals and Clinics
- Diagnostic Centers
- Research and Academic Institutions
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profile:
- Bristol Myers Squibb
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Boehringer Ingelheim International GmbH
- Sanofi
- AbbVie Inc.
- Braun SE
- Becton, Dickinson and Company
- Bicakcilar
- Biometrix
- Cook Medical
- Grena
- Redax
- Rocket Medical
- Smith Medical

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Pleural Diseases, By Disease Type
- Market Pleural Diseases, By Diagnostic Tools
- Market Pleural Diseases, By Treatment Modalities
- Market Pleural Diseases, By End User
- Market Pleural Diseases, By Geography/Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing Prevalence of Respiratory diseases
- Restraints
Limited Availability of Expertise and Resources
- Opportunities
Emerging Biomarkers and Precision Medicine
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Pleural Diseases Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Pleural Diseases Market, By Disease Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pleurisy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Pleural Effusion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Pneumothelioma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Mesothelioma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Pleural Diseases Market, By Diagnostic Tools, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Imaging Techniques
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Molecular Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 20218-2032, (US$ Billion)
Thoracoscopy and Pleuroscopy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Global Pleural Diseases Market, By Treatment Modalities, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Thoracentesis and Pleurodesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Minimally Invasive Interventions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Surgical Interventions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

8. Global Pleural Diseases Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Research and Academic Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

9. Global Pleural Diseases Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)

10. Competitive Landscape

Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Braun SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bicakcilar
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Biometrix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Cook Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Grena
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Redax
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Rocket Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Smith Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

11. Section

Research Methodology
About us

胸膜疾患市場：疾患タイプ別、診断ツール別、治療法別、エンドユーザー別、地域別

Pleural Diseases Market, By Disease Type, By Diagnostic Tools, By Treatment Modalities, By End User, By Geography

市場力学：

目次

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界の胸膜疾患市場- コロナウイルス（COVID-19）パンデミックの影響

第5章世界の胸膜疾患市場、疾患タイプ別、2020年～2032年

第6章世界の胸膜疾患市場、診断ツール別、2020年～2032年

第7章世界の胸膜疾患市場、治療法別、2020年～2032年

第8章世界の胸膜疾患市場、エンドユーザー別、2020年～2032年

第9章世界の胸膜疾患市場、地域別、2020年～2032年

第10章競合情勢

第11章セクション

Market Dynamics:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Pleural Diseases Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Pleural Diseases Market, By Disease Type, 2020-2032, (US$ Bn)

6. Global Pleural Diseases Market, By Diagnostic Tools, 2020-2032, (US$ Bn)

7. Global Pleural Diseases Market, By Treatment Modalities, 2020-2032, (US$ Bn)

8. Global Pleural Diseases Market, By End User, 2020-2032, (US$ Bn)

9. Global Pleural Diseases Market, By Region, 2020-2032, (US$ Bn)

10. Competitive Landscape

11. Section

胸膜疾患市場：疾患タイプ別、診断ツール別、治療法別、エンドユーザー別、地域別

Pleural Diseases Market, By Disease Type, By Diagnostic Tools, By Treatment Modalities, By End User, By Geography

市場力学：

目次

第1章 調査の目的と前提条件

第2章 市場の展望

第3章 市場力学、規制、動向分析

第4章 世界の胸膜疾患市場- コロナウイルス（COVID-19）パンデミックの影響

第5章 世界の胸膜疾患市場、疾患タイプ別、2020年～2032年

第6章 世界の胸膜疾患市場、診断ツール別、2020年～2032年

第7章 世界の胸膜疾患市場、治療法別、2020年～2032年

第8章 世界の胸膜疾患市場、エンドユーザー別、2020年～2032年

第9章 世界の胸膜疾患市場、地域別、2020年～2032年

第10章 競合情勢

第11章 セクション

Market Dynamics:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Pleural Diseases Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Pleural Diseases Market, By Disease Type, 2020-2032, (US$ Bn)

6. Global Pleural Diseases Market, By Diagnostic Tools, 2020-2032, (US$ Bn)

7. Global Pleural Diseases Market, By Treatment Modalities, 2020-2032, (US$ Bn)

8. Global Pleural Diseases Market, By End User, 2020-2032, (US$ Bn)

9. Global Pleural Diseases Market, By Region, 2020-2032, (US$ Bn)

10. Competitive Landscape

11. Section

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界の胸膜疾患市場- コロナウイルス（COVID-19）パンデミックの影響

第5章世界の胸膜疾患市場、疾患タイプ別、2020年～2032年

第6章世界の胸膜疾患市場、診断ツール別、2020年～2032年

第7章世界の胸膜疾患市場、治療法別、2020年～2032年

第8章世界の胸膜疾患市場、エンドユーザー別、2020年～2032年

第9章世界の胸膜疾患市場、地域別、2020年～2032年

第10章競合情勢

第11章セクション